Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Chronic aspartame intake causes changes in the trans-sulphuration pathway, glutathione depletion and liver damage in mice.

Finamor I, Pérez S, Bressan CA, Brenner CE, Rius-Pérez S, Brittes PC, Cheiran G, Rocha MI, da Veiga M, Sastre J, Pavanato MA.

Redox Biol. 2017 Apr;11:701-707. doi: 10.1016/j.redox.2017.01.019. Epub 2017 Feb 1.

2.

N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.

Domenech M, García E.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01992-16. doi: 10.1128/AAC.01992-16. Print 2017 Feb.

PMID:
27919900
3.

The 100 most influential publications in paracetamol poisoning treatment: a bibliometric analysis of human studies.

Zyoud SH, Waring WS, Al-Jabi SW, Sweileh WM, Awang R.

Springerplus. 2016 Sep 13;5(1):1534. doi: 10.1186/s40064-016-3240-z. eCollection 2016.

4.

Corticostriatal circuitry in regulating diseases characterized by intrusive thinking.

Kalivas BC, Kalivas PW.

Dialogues Clin Neurosci. 2016 Mar;18(1):65-76. Review.

5.

N-Acetylcysteine reduces hyperacute intermittent hypoxia-induced sympathoexcitation in human subjects.

Jouett NP, Moralez G, White DW, Eubank WL, Chen S, Tian J, Smith ML, Zimmerman MC, Raven PB.

Exp Physiol. 2016 Mar;101(3):387-96. doi: 10.1113/EP085546. Epub 2016 Feb 4.

6.

Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury.

Takhtfooladi HA, Hesaraki S, Razmara F, Takhtfooladi MA, Hajizadeh H.

J Bras Pneumol. 2016 Jan-Feb;42(1):9-14. doi: 10.1590/S1806-37562016000000183. English, Portuguese.

7.

The antioxidant N-Acetylcysteine does not improve glucose tolerance or β-cell function in type 2 diabetes.

Szkudlinska MA, von Frankenberg AD, Utzschneider KM.

J Diabetes Complications. 2016 May-Jun;30(4):618-22. doi: 10.1016/j.jdiacomp.2016.02.003. Epub 2016 Feb 5.

PMID:
26922582
8.

Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects.

Al-Samhari MM, Al-Rasheed NM, Al-Rejaie S, Al-Rasheed NM, Hasan IH, Mahmoud AM, Dzimiri N.

Exp Biol Med (Maywood). 2016 Mar;241(5):509-18. doi: 10.1177/1535370215619707. Epub 2015 Dec 6.

9.

Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases.

Li M, Gao W, Ma J, Zhu Y, Li X.

Exp Ther Med. 2015 Aug;10(2):689-692. Epub 2015 May 21.

10.

Quercetin conjugated poly(β-amino esters) nanogels for the treatment of cellular oxidative stress.

Gupta P, Authimoolam SP, Hilt JZ, Dziubla TD.

Acta Biomater. 2015 Nov;27:194-204. doi: 10.1016/j.actbio.2015.08.039. Epub 2015 Aug 28.

11.

Pseudoporphyria in a peritoneal dialysis patient.

Velioglu A, Ergun T, Ozener C.

Perit Dial Int. 2015 Mar-Apr;35(2):234-5. doi: 10.3747/pdi.2014.00309. No abstract available.

12.

Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.

Mansour MR, Reed C, Eisenberg AR, Tseng JC, Twizere JC, Daakour S, Yoda A, Rodig SJ, Tal N, Shochat C, Berezovskaya A, DeAngelo DJ, Sallan SE, Weinstock DM, Izraeli S, Kung AL, Kentsis A, Look AT.

Br J Haematol. 2015 Jan;168(2):230-8. doi: 10.1111/bjh.13115. Epub 2014 Sep 26.

13.

Novel acetylcysteine regimens for treatment of paracetamol overdose.

Waring WS.

Ther Adv Drug Saf. 2012 Dec;3(6):305-15. doi: 10.1177/2042098612464265. Review.

14.

Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats.

Hsieh CC, Hsieh SC, Chiu JH, Wu YL.

J Tradit Complement Med. 2014 Jan;4(1):64-71. doi: 10.4103/2225-4110.124351.

15.

N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma.

Patel SP, Sullivan PG, Pandya JD, Goldstein GA, VanRooyen JL, Yonutas HM, Eldahan KC, Morehouse J, Magnuson DS, Rabchevsky AG.

Exp Neurol. 2014 Jul;257:95-105. doi: 10.1016/j.expneurol.2014.04.026. Epub 2014 May 5.

16.

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.

Bavarsad Shahripour R, Harrigan MR, Alexandrov AV.

Brain Behav. 2014 Mar;4(2):108-22. doi: 10.1002/brb3.208. Epub 2014 Jan 13. Review.

17.

N-acetylcysteine reverses cardiac myocyte dysfunction in a rodent model of behavioral stress.

Chen F, Hadfield JM, Berzingi C, Hollander JM, Miller DB, Nichols CE, Finkel MS.

J Appl Physiol (1985). 2013 Aug 15;115(4):514-24. doi: 10.1152/japplphysiol.01471.2012. Epub 2013 May 30.

18.

The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain.

Ehsani M, Moghadamnia AA, Zahedpasha S, Maliji G, Haghanifar S, Mir SM, Kani NM.

Daru. 2012 Sep 10;20(1):30. doi: 10.1186/2008-2231-20-30.

19.

Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service.

Bryczkowski C, Geib AJ.

J Med Toxicol. 2012 Dec;8(4):424-31. doi: 10.1007/s13181-012-0261-z. Review. No abstract available.

20.

N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.

Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE.

Neuropsychopharmacology. 2012 Aug;37(9):2143-52. doi: 10.1038/npp.2012.66. Epub 2012 May 2.

Supplemental Content

Support Center